Recently it was also shown that in papillary thyroid carcinoma crizotinib acts as a antitumor agent by inhibiting phosphorylation of MET, AKT and its downstream signaling molecules and synergizes with TRAIL in suppression of tumor growth22. The gene discussed is TNFSF10; the disease is neoplasm.